Zelba, Henning, Weide, Benjamin, Martens, Alexander, Derhovanessian, Evelyna, Bailur, Jithendra Kini, Kyzirakos, Christina, Pflugfelder, Annette, Eigentler, Thomas K., Di Giacomo, Anna Maria, Maio, Michele, Aarntzen, Erik H.J.G., de Vries, Jolanda, Sucker, Antje, Schadendorf, Dirk, Büttner, Petra, Garbe, Claus, and Pawelec, Graham (2014) Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by Melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma. Clinical Cancer Research, 20 (16). pp. 4390-4399.

Meckbach, Diana, Keim, Ulrike, Richter, Sabina, Leiter, Ulrike, Eigentler, Thomas K., Bauer, Jürgen, Pflugfelder, Annette, Büttner, Petra, Garbe, Claus, and Weide, Benjamin (2014) BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy. PLoS ONE, 9 (2). e89218. pp. 1-7.

Weide, Benjamin, Faller, Christine, Elsässer, Margrit, Büttner, Petra, Pflugfelder, Annette, Leiter, Ulrike, Eigentler, Thomas Kurt, Bauer, Jürgen, Meier, Friedegund, and Garbe, Claus (2013) Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour. PLoS ONE, 8 (6). e66953. pp. 1-7.

Weide, Benjamin, Faller, Christine, Büttner, Petra, Pflugfelder, Annette, Leiter, Ulrike, Eigentler, Thomas Kurt, Bauer, Jürgen, Forschner, Andrea, Meier, Friedegund, and Garbe, Claus (2013) Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis. PLoS ONE, 8 (4). e63137. pp. 1-6.

Weide, Benjamin, Zelba, Henning, Derhovanessian, Evelyna, Pflugfelder, Annette, Eigentler, Thomas K., Giacomo, Anna Maria Di, Maio, Michele, Aarntzen, Erik H.J.G., de Vries, I. Jolanda, Sucker, Antje, Schadendorf, Dirk, Büttner, Petra, Garbe, Claus, and Pawelec, Graham (2012) Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis. Journal of Clinical Oncology, 30 (15). pp. 1835-1841.